These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Epidemiological study on human prostate cancer in Wuhan City].
    Author: Du S, Shi L, Zhu W, Zhai F.
    Journal: Wei Sheng Yan Jiu; 1997 Sep; 26(5):356-9. PubMed ID: 10325655.
    Abstract:
    In America, Canada and many European countries, prostate cancer is the most common cancer and the second leading cause of cancer death in men. In China, the morbidity rate and mortality rate of prostate cancer are unknown. Based on the reports of Wuhan cancer surveillance in 1990-1992, this study researched the epidemiological characterics of prostate cancer. The results showed that morbidity rate and mortality rate in Wuhan city are 1.37 and 0.75 per 100,000 respectively, and the standardized morbidity rate and standardized mortality rate are 1.10 and 0.66 per 100,000 respectively. They also showed that history of urinary diseases (OR = 5.42, 95% confidence interval (CI): 1.56-18.83), children number with more than 3 (OR = 2.43, 95% CI: 1.17-5.02), coitus with more than 3 times per week in youth (OR = 3.38, 95% CI: 1.51-7.58), frequent use of sexual drugs (OR = 4.12, 95% CI: 1.65-10.25) and high body mass index (OR = 2.58; 95% CI: 1.30-5.11) are identified as risk factors of prostate cancer statistically, but physical labor (OR = 0.35, 95% CI: 0.17-0.71) and age of first nocturnal emission after 18 years old (OR = 0.20, 95% CI: 0.08-0.52) are protective factors.
    [Abstract] [Full Text] [Related] [New Search]